Novan Inc (NOVN)

NASDAQ
7.88
+0.40(+5.35%)
After Hours
8.05
+0.17(+2.16%)
- Real-time Data
  • Volume:
    663,027
  • Bid/Ask:
    7.80/8.10
  • Day's Range:
    7.53 - 8.13

NOVN Overview

Prev. Close
7.48
Day's Range
7.53-8.13
Revenue
4.53M
Open
7.53
52 wk Range
3-25.9
EPS
-2.69
Volume
663,027
Market Cap
148.2M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,929,331
P/E Ratio
-
Beta
-0.06
1-Year Change
16.74%
Shares Outstanding
18,807,042
Next Earnings Date
16 Nov 2021
What is your sentiment on Novan Inc?
or
Market is currently closed. Voting is open during market hours.

Novan Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellSellStrong SellBuy
Technical IndicatorsStrong SellStrong SellSellStrong SellStrong Buy
SummaryStrong SellStrong SellSellStrong SellStrong Buy

Novan Inc Company Profile

Novan Inc Company Profile

Employees
23

Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete’s foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is based in Durham, North Carolina.

Read More
  • Moon landing coming 🚀
    0
    • split
      0
  • buy or bye
    1
    • Buy
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.